Open AccessSorafenib and Sunitinib
Author(s) -
Kim AeRang,
Balis Frank M.,
Widemann Brigitte C.
Publication year - 2009
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2009-0088
Subject(s) - sunitinib , sorafenib , medicine , pharmacology , pharmacokinetics , oncology , toxicity , renal cell carcinoma , hepatocellular carcinoma
Learning Objectives After completing this course, the reader will be able to: Enumerate the clinical indications for sorafenib and sunitinib therapy. Describe the mechanism of action and the pharmacokinetics of sorafenib and sunitinib. Analyze the toxicity profile and appraise the therapeutic effects associated with sorafenib and sunitinib.This article is available for continuing medical education credit at CME.TheOncologist.com .